Cardiovascular Outcomes Update in SGLT-2 Inhibitors

January 14, 2021

Patients with diabetes, especially advanced diabetes, typically have comorbid cardiovascular disease. Current practice is to manage hyperglycemia via insulin, metformin, or selection of additional agents based on cost, patient preference, and side effect profiles. Furthermore, the cardiovascular disease is managed via the ACEi/ARBs, beta-blockers, calcium channel blockers and other cardiovascular agents. SGLT-2 inhibitor manufacturers recently published data to support the use of SGLT-2 inhibitors in cardiovascular disease with or without diabetes. This CE presentation will present new and existing data for the use of SGLT-2 inhibitors in cardiovascular disease. This will help pharmacy staff and health care professionals to make appropriate decisions for their patients regarding their chronic disease management.

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist learning objectives

  1. Describe cardiovascular mechanisms of SGLT-2 inhibitors
  2. Review and discuss recent cardiovascular outcomes from SGLT-2 trials
  3. Outline placement of SGLT-2 inhibitors in treatment algorithms

Pharmacy technician learning objectives

  1. Recognize medications used in diabetes and heart failure
  2. Describe the role of SGLT-2 medications in diabetes and heart failure
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CE - Attendance
Course opens: 
Course expires: 
Event starts: 
01/14/2021 - 12:00pm CST
Event ends: 
01/14/2021 - 1:00pm CST
Newark, DE
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose
Planning committee members
Kesha Wright, PharmD
Clinical Pharmacist
Shannan Street, PharmD
PGY-1 Pharmacy Resident
Course reviewer
James Lichauer, PharmD, BCPS, FASHP
PI Program Director, Pharmacy
Shannan Street, PharmD
PGY-1 Pharmacy Resident
Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and ChristianaCare.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation Statements:
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-21-074-L01-P
Universal Activity Number: JA0006103-9999-21-074-L01-T
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CE - Attendance
Please login or register to take this course.